A psychiatrist and their patient reflect on treatment.
What sleep disorders are common in older adults and what are the associated risk factors and correlates?
What is the model minority myth and how is it harming us all?
An early career psychiatrist and resident psychiatrist reflect on their racialized experiences in predominantly white spaces and the impact on their lives.
What social and scientific advances could help elite athletes with mental illnesses?
Is the mental health system crumbling? One psychiatrist wonders who will take up the mantles of the innovative and socially conscious physicians who came before.
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
More than ever, psychiatrists are encountering patients who may have never experienced mental health issues.
Here’s how providing tailored mental health support for health care professionals can help alleviate burnout and other mental health challenges within health care.
In this CME, review the pathophysiology of anti-N-methyl-D-aspartate receptor encephalitis.
Cryptocurrency can be complicated, but with these 5 tips, you can plan your best investment moves.
One doctor shares 3 interconnected pieces relating to the 3 Ps: prose, poetry, and prayer.
Don't miss this session at the APA 2023 Annual Meeting in San Francisco!
Cannabis use disorder and nonadherence: How can we best educate patients?
How to help individuals caught in human trafficking: person-centered, culturally humble, trauma-informed care.
How do we find the right treatments for our patients with schizophrenia at every step of their journey?
Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
In a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
As the COP-26 (Conference of the Parties) gets ready to convene to discuss climate change, it is crucial for them to consider brain science.
Faced with the trend toward shorter length of stay in inpatient psychiatric units, practitioners and patients in need of care face dramatic changes in treatment.
The president of the San Diego Psychiatric Society gives us a glimpse into the city for the upcoming 2022 Annual Psychiatric Times World CME Conference.
Experts share their best practices and tips.
While there are no FDA-approved medications available for CUD, some studies show potential off-label utility in mitigating withdrawal and maintaining abstinence. Learn more in this CME article.
Researchers discuss new research on buprenorphine, the “gold standard” treatment for opioid use disorder at the APA Annual Meeting.
Online environments have revolutionized the lives of young SGM individuals, but also created unforeseen issues...
Psychiatric Times® salutes our armed forces and remembers those who have fallen during service.
Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.